Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Takei

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Breast Cancer (Tokyo, Japan)|December 3, 2002
Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer casesHiroyuki Takei, Kimito Suemasu, Masafumi Kurosumi, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|April 9, 2005
[New method of estimating effective energy for X-ray CT scanners]Hiroyuki Nagashima, Shinichi Sunaga, Toyohisa Mitome, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 18, 2018
Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trialAsao Ogawa, Yasuyuki Okumura, Daisuke Fujisawa, et al.
Breast Cancer (Tokyo, Japan)|November 8, 2007
Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspectiveHiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, et al.
The Lancet. Oncology|January 24, 2012
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trialNorikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, et al.
Scientific Reports|January 21, 2018
Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patientsMasaki Sekino, Akihiro Kuwahata, Tetsu Ookubo, et al.
Breast Cancer (Tokyo, Japan)|November 25, 2010
Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?Hiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, et al.
Breast Cancer (Tokyo, Japan)|June 13, 2013
Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center studyAtsumori Hamahata, Kazuyuki Kubo, Hiroyuki Takei, et al.
The Breast Journal|December 25, 2009
True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatmentTakashi Yoshida, Hiroyuki Takei, Masafumi Kurosumi, et al.
Breast (Edinburgh, Scotland)|August 24, 2007
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different racesJunichi Kurebayashi, Takuya Moriya, Takanori Ishida, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Breast Cancer (Tokyo, Japan)|December 3, 2002
Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer casesHiroyuki Takei, Kimito Suemasu, Masafumi Kurosumi, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|April 9, 2005
[New method of estimating effective energy for X-ray CT scanners]Hiroyuki Nagashima, Shinichi Sunaga, Toyohisa Mitome, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 18, 2018
Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trialAsao Ogawa, Yasuyuki Okumura, Daisuke Fujisawa, et al.
Breast Cancer (Tokyo, Japan)|November 8, 2007
Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspectiveHiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, et al.
The Lancet. Oncology|January 24, 2012
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trialNorikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, et al.
Scientific Reports|January 21, 2018
Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patientsMasaki Sekino, Akihiro Kuwahata, Tetsu Ookubo, et al.
Breast Cancer (Tokyo, Japan)|November 25, 2010
Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?Hiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, et al.
Breast Cancer (Tokyo, Japan)|June 13, 2013
Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center studyAtsumori Hamahata, Kazuyuki Kubo, Hiroyuki Takei, et al.
The Breast Journal|December 25, 2009
True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatmentTakashi Yoshida, Hiroyuki Takei, Masafumi Kurosumi, et al.
Breast (Edinburgh, Scotland)|August 24, 2007
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different racesJunichi Kurebayashi, Takuya Moriya, Takanori Ishida, et al.
Pageof 18